Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuchuan Xue
Institution:
First Hospital of China Medical University
Observed institutions:
First Hospital of China Medical University,
China Medical University
ORCID:
0000-0002-6424-5782
Observed ORCID:
0000-0002-6424-5782
OpenAlex ID:
A5025695672
Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis
2022
·
Keda Yang
, Fangming Cao
, et al.
·
Frontiers in Physiology
·
66
PDF
Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era
2021
·
Keda Yang
, Guangfu Wen
, et al.
·
Frontiers in Immunology
·
31
PDF
Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder
2025
·
Qichang Liu
, Yuchuan Xue
, et al.
·
Frontiers in Endocrinology
·
17
PDF
Research Progress in the Treatment of Complications and Sequelae of COVID-19
2021
·
Jinpeng Wang
, Kuoyun Zhu
, et al.
·
Frontiers in Medicine
·
16
PDF
Emerging Roles of Protein O‐ GlcNAcylation in Bone Remodeling: New Insights Into Osteoporosis
2025
·
Jinpeng Wang
, Site Xu
, et al.
·
Acta Physiologica
·
8
PDF
Cascades From Caspase‐Dependent Osteoblast Death to Purinergic Signaling in the Pathogenesis of Osteoporosis: Novel Roles of Caspases in Bone Remodeling
2026
·
Site Xu
, Yunhan Wang
, et al.
·
Comprehensive physiology
Show more works
View as search
Works count:
6
Citation count:
138
H-index:
5
I10-index:
4
Year
Topic
Type